Skip to main content

Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease

Publications

Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

Auteurs: Niels Dammes, Meir Goldsmith, Srinivas Ramishetti, Jason L. J. Dearling, Nuphar Veiga, Alan B. Packard & Dan Peer
Publié dans: Nature Nanotechnology, 2021, ISSN 1748-3387
Éditeur: Nature Publishing Group
DOI: 10.1038/s41565-021-00928-x

Therapeutic mRNA delivery to leukocytes

Auteurs: Granot-Matok Y, Kon E, Dammes N, Mechtinger G, and Peer D
Publié dans: Journal of controlled release, 2019, ISSN 0168-3659
Éditeur: Elsevier BV
DOI: 10.1016/j.jconrel.2019.05.032

Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target

Auteurs: Veiga N, Goldsmith M, Diesendruck Y, Ramishetti S, Rosenblum D, Elinav E, Behlke MA, Benhar I, and Peer D.
Publié dans: Journal of controlled release, 2019, ISSN 0168-3659
Éditeur: Elsevier BV
DOI: 10.1016/j.jconrel.2019.10.001

rgeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes

Auteurs: Veiga N, Diesendruck Y, and Peer D
Publié dans: Advanced drug delivery reveiws, 2020, ISSN 0169-409X
Éditeur: Elsevier BV
DOI: 10.1016/j.addr.2020.04.002

Engineering Lymphocytes with RNAi

Auteurs: Ramishetti S, and Peer D
Publié dans: Advanced drug delivery reveiws, 2018, ISSN 0169-409X
Éditeur: Elsevier BV
DOI: 10.1016/j.addr.2018.12.002

Progress and challenges towards targeted delivery of cancer therapeutics

Auteurs: Daniel Rosenblum, Nitin Joshi, Wei Tao, Jeffrey M. Karp, Dan Peer
Publié dans: Nature Communications, 9/1, 2018, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-018-03705-y

A modular platform for targeted RNAi therapeutics

Auteurs: Ranit Kedmi, Nuphar Veiga, Srinivas Ramishetti, Meir Goldsmith, Daniel Rosenblum, Niels Dammes, Inbal Hazan-Halevy, Limor Nahary, Shani Leviatan-Ben-Arye, Michael Harlev, Mark Behlke, Itai Benhar, Judy Lieberman, Dan Peer
Publié dans: Nature Nanotechnology, 13/3, 2018, Page(s) 214-219, ISSN 1748-3387
Éditeur: Nature Publishing Group
DOI: 10.1038/s41565-017-0043-5

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

Auteurs: Nuphar Veiga, Meir Goldsmith, Yasmin Granot, Daniel Rosenblum, Niels Dammes, Ranit Kedmi, Srinivas Ramishetti, Dan Peer
Publié dans: Nature Communications, 9/1, 2018, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-018-06936-1

Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines

Auteurs: Inbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, Shoshy Mizrahy, Brandon D. Ng, Dan Peer
Publié dans: Journal of Controlled Release, 244, 2016, Page(s) 149-156, ISSN 0168-3659
Éditeur: Elsevier BV
DOI: 10.1016/j.jconrel.2016.07.052

Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes

Auteurs: Shoshy Mizrahy, Inbal Hazan-Halevy, Niels Dammes, Dalit Landesman-Milo, Dan Peer
Publié dans: Molecular Therapy, 2017, ISSN 1525-0016
Éditeur: Nature Publishing Group
DOI: 10.1016/j.ymthe.2017.03.001

Monoclonal antibody-based molecular imaging strategies and theranostic opportunities

Auteurs: Niels Dammes, Dan Peer
Publié dans: Theranostics, 10/2, 2020, Page(s) 938-955, ISSN 1838-7640
Éditeur: Ivyspring International Publisher
DOI: 10.7150/thno.37443